Polyglandular autoimmune syndromes
Autoimmune failure of multiple endocrine glands (APS-1, APS-2)
Overview
Autoimmune destruction of several endocrine glands together. APS type 1 (AIRE gene, childhood): the triad of chronic mucocutaneous candidiasis, hypoparathyroidism and Addison's disease. APS type 2 (Schmidt, adults, commoner): Addison's disease with autoimmune thyroid disease and/or type 1 diabetes. Recognise the clustering — one autoimmune endocrinopathy should prompt looking for the others.
Recognise
- APS-1 (childhood): mucocutaneous CANDIDIASIS + HYPOPARATHYROIDISM + ADDISON'S (± other organ-specific autoimmunity)
- APS-2 (adults, commonest): ADDISON'S + autoimmune THYROID disease and/or type 1 DIABETES
- Often other autoimmune disease (vitiligo, pernicious anaemia, coeliac, premature ovarian insufficiency)
Red flags
- Underlying Addisonian crisis risk; new autoimmune endocrinopathy → screen for the others
Differentials & how to tell them apart
Investigations
Hormone profiles of the involved glands (cortisol/ACTH, calcium/PTH, TFTs, glucose) + relevant autoantibodies (21-hydroxylase, TPO, GAD); AIRE genetics (APS-1); screen periodically.
Management
Replace each deficient gland + screen for and monitor the others
- 1When one autoimmune endocrinopathy is found, SCREEN for the others (the syndrome clusters). Replace each deficient hormone — glucocorticoid before thyroxine if both adrenal and thyroid are involved.Gate: In combined adrenal + thyroid disease, replace GLUCOCORTICOID before levothyroxine (thyroxine first can precipitate an adrenal crisis); one autoimmune gland failure should trigger looking for the cluster
- 2Lifelong replacement and periodic re-screening for emerging endocrinopathies; family awareness.
Key points
Clusters of autoimmune endocrine failure: APS-1 = candidiasis + hypoparathyroidism + Addison's (kids); APS-2 = Addison's + thyroid ± T1DM (adults). Find one → look for the rest; steroid before thyroxine.
Monitor & prognosis
Periodic hormone screening; new autoimmunity.
Good on replacement.
Source: Society for Endocrinology